2001

November 13, 2001
Panacea Pharmaceuticals, Inc. Presents Findings on its Alzheimer's Drug Development Program at 31st Annual Meeting of the Society for Neuroscience

November 1, 2001
Panacea Pharmaceuticals, Inc. Presents New Findings on HAAH Oncology Program At AACR-NCI-EORTC International Conference

July 25, 2001
Panacea Pharmaceuticals, Inc. Awarded SBIR Grant for Parkinson's Disease Drug Development

July 18, 2001
Panacea Pharmaceuticals, Inc. Announces New Findings Supporting Its HAAH Oncology Program

June 22, 2001
Panacea Pharmaceuticals, Inc. Presents Progress on Alzheimer's Disease Treatment Technology at AANP Annual Meeting

June 21, 2001
Panacea Pharmaceuticals, Inc. to Present at BIO 2001 International Investor & Partnering Forum

May 10, 2001
Panacea Pharmaceuticals, Inc. Appoints Lawrence Glass as Senior Vice-President for Corporate Development

March 13, 2001
Panacea Pharmaceuticals, Inc. Appoints Operations and Technical Director for Diagnostic Division

February 16, 2001
Panacea Pharmaceuticals, Inc. to Present at BIO CEO & Investor Conference

February 7, 2001
Panacea Pharmaceuticals, Inc. Announces Collaboration with Massachusetts Institute of Technology Utilizing Breakthrough Technology for Engineering Ultra Affinity Antibodies

January 18, 2001
Panacea Pharmaceuticals, Inc. Appoints Donald A. Zelm as Vice President for Finance

January 10, 2001
Panacea Pharmaceuticals, Inc. Announces Members of Clinical Advisory Board

January 3, 2001
Panacea Pharmaceuticals, Inc. Announces Appointment of Chief Patent Counsel